No Data
No Data
8 Out of 12 S&P 500 Healthcare Companies Beat Profit Consensus This Week: Earnings Scorecard
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
Buy Rating Affirmed for Kyverna Therapeutics on Promising KYV-101 Drug Efficacy and Safety Data
In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on Kyverna Therapeutics, Inc. (KYTX – Research Report), with a price target of $44.00.
Buy Rating Affirmed for Kyverna Therapeutics on Promising KYV-101 Clinical Advances
Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Kyverna Therapeutics, Inc. (KYTX – Research Report), retaining the price target of $40.00.
Kyverna Therapeutics to Attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients With Neurological Autoimmune Diseases
Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for...
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in
No Data